Imatinib mesylate from ABBEXA LTD

Search, find, compare suppliers for Imatinib mesylate products.

Edit 
Product NameImatinib mesylate
DescriptionImatinib mesylate is a small molecule which can act as a BCR-ABL inhibitor. It is provided as a powder.

This product acts on the following target types: Kinase, Cytochrome.
This product may be of interest in the following research areas and diseases: Cancer.
This product may act as a Coronavirus inhibitor: Inhibits SARS-CoV and MERS-CoV in cells.

Please note that our chemical products are for scientific research use only and are not for medical or veterinary use. This product can only be dispatched to a scientific business or laboratory address. MW: 493.62 g/mol 96.11 g/mol
Size20 mg, 100 mg
Concentrationn/a
Applicationsn/a
Other NamesImatinib mesylate, 4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide methanesulfonate, Gleevec, STI571, 220127-57-1
Gene, Accession, CAS #CAS: 220127-57-1
Catalog #abx076675
Priceplease inquire
Order / More InfoImatinib mesylate from ABBEXA LTD
Product Specific Referencesn/a
ABBEXA LTD
ABBEXA LTD
ABBEXA LTD
181 Cambridge Science Park
Cambridge, CB4 0GJ UK
P: +44 (0) 1223 755950

Customer Service: info@abbexa.com
Technical Support: support@abbexa.com
Orders: orders@abbexa.com

https://www.abbexa.com

U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413

Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950


Profile of ABBEXA LTD
Return to Products

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.